Company
CRISPR Therapeutics AG
CRSP · CIK 0001674416
Acquisition (code M) of 10,400 shares at $13.62 per share.
Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M
Traded Sep 22, 2026 · Disclosed Sep 24, 2026
Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →
Sale of 10,400 shares at $60.2365 per share.
Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code S
Traded Sep 22, 2026 · Disclosed Sep 24, 2026
Source: SEC Form 4 · 0001193125-26-401237 · filed 2026-09-24 · View filing →
Acquisition (code M) of 30,000 shares at $14 per share.
Reporting Person Behbahani Ali · Transaction Code M
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →
Sale of 13,679 shares at $57.0901 per share.
Reporting Person Behbahani Ali · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001193125-26-396944 · filed 2026-09-21 · View filing →